Last reviewed · How we verify
Jatenzo
Jatenzo is a Small molecule drug developed by University of Miami. It is currently FDA-approved.
At a glance
| Generic name | Jatenzo |
|---|---|
| Sponsor | University of Miami |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Body Composition Assessment in Transgender Population.
- Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening (PHASE4)
- Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism (PHASE2)
- Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC (PHASE2)
- Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response (PHASE2)
- Does Human Skeletal Muscle Possess an Epigenetic Memory of Testosterone? (PHASE2, PHASE3)
- Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance (PHASE4)
- Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Jatenzo CI brief — competitive landscape report
- Jatenzo updates RSS · CI watch RSS
- University of Miami portfolio CI
Frequently asked questions about Jatenzo
What is Jatenzo?
Jatenzo is a Small molecule drug developed by University of Miami.
Who makes Jatenzo?
Jatenzo is developed and marketed by University of Miami (see full University of Miami pipeline at /company/university-of-miami).
What development phase is Jatenzo in?
Jatenzo is FDA-approved (marketed).
Related
- Manufacturer: University of Miami — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing